ARTURO BRAVO NUEVO, PHD
Department of Bio-Medical Sciences - Philadelphia
Associate Professor of Neuroscience


Arturo Bravo Nuevo, PhD

Contact

Email: arturobr@pcom.edu
Office: 215-871-6345
Publications and Selected Works

Dr. Bravo Nuevo is an associate professor in the Department of Bio-Medical Sciences. He lectures on subjects related to the central nervous system, the visual system, retinal degenerative diseases and muscle physiology.

Dr. Bravo Nuevo has lectured in several universities including Sydney University, Australian National University, Harvard University and Aarhus University. He has mentored several high school and college students from Drexel University and Bryn Mawr college through masters programs and research projects.

He has active scientific and academic collaborations with several international universities in Australia, Spain and Denmark.

Dr. Bravo Nuevo is listed as the inventor in several patents. He is a senior advisor for several biotechnology companies and founded his own pharmaceutical company in 2014.

 

  • Education

    • Post-Doctoral Training at Harvard Medical School (Boston, MA)
    • Ph.D. from Australian National University (Canberra, Australia)
    • B.A and M.Sc. from Universidad Autonoma of Madrid (Madrid, Spain)
  • Research

    Dr. Bravo Nuevo has been working on neuroprotection of the retinal neuronal cells, muscle physiology and diabetes.

    Most recently, he has worked in the role that Myo/Nog cells have to prevent blindness caused by retinal degenerations, and slowing the progression of plaque formation in Alzheimer's disease.

  • Awards

    Current
    • Principal Investigator. “Role of Myo/Nog cells in Neuroprotection.” Anonymous donation - $284,318
    Past
    • Co-Principal Investigator on a $250,000 grant from March of Dimes. “Regulation of the Development of Anterior Eye Structures and Extra-ocular Muscles by Epiblast-Derived Skeletal Muscle Stem Cells”
        • Subproject: Role of Myo/Nog cells in the Developing Retina
    • Principal Investigator on a $60,000 grant from Dynamis Therapeutics Inc. “Meglumine effects on glycemic control on Type 2 diabetes and associated
      complications”
    • Co-investigator on a $300,000 grant from the American Diabetes Association (705RA10) “RhoB as a therapeutic target for diabetic microvascular complications”.
    • Awarded an AU$ 80,000 merit scholarship by the Department of Anatomy and Histology of the University of Sydney for doctoral studies.
    • Awarded the Outstanding International Student Scholarship by the 2000 – 2004 Australian Government.
    • Granted Young Investigators Travel Award for the Xth International 2002 Symposium in Retinal Degeneration
  • Memberships

    • American Diabetes Association
    • Association for Research in Vision and Ophthalmology
  • Grants

    Principal Investigator. “Role of Myo/Nog cells in Neuroprotection.”
    Anonymous donation
    $284,318